11 – 20 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Systemic lupus erythematosus : Still a challenge for physicians
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Evolving Therapeutic Options for Polycythemia Vera : Perspectives of the Canadian Myeloproliferative Neoplasms Group
(
- Contribution to journal › Debate/Note/Editorial
- 2013
-
Mark
Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin
(
- Contribution to journal › Article
- 2008
-
Mark
Anti-Tumor Effects of CysLT2R in Epithelial Cancer
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: A randomized phase II study from the Nordic Lymphoma Group
(
- Contribution to journal › Article
- 2007
-
Mark
TRIM22/Staf50 - a novel target gene of the tumor suppressor p53
(
- Thesis › Doctoral thesis (compilation)
- 2005
-
Mark
Partial splenic embolization as pretreatment for antiviral therapy in hepatitis C virus infection
(
- Contribution to journal › Article
-
Mark
Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: Long-term follow-up
(
- Contribution to journal › Article
-
Mark
Multiple Sclerosis: Studies of the Interferon system and search for infectious agents
2005)(
- Thesis › Doctoral thesis (compilation)
- 2002
-
Mark
Low expression of interferon regulatory factor-1 and identification of novel exons skipping in patients with chronic myeloid leukaemia
(
- Contribution to journal › Article